🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of ustekinumab compar...
Status
Terminated
Location
Tokyo Medical and Dental University Hospital
Start Date
2021-09-15
Trial ID
NCT04882072
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ustekin...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-10
Trial ID
NCT02407236
Treatments Being Tested
The purpose of this study is to examine the safety and efficacy of CNTO 127...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00265122
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab and CN...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01645280
The purpose of this study is to evaluate the effectiveness and safety of CN...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00267956
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ustekin...
Status
Completed
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02698475
Treatments Being Tested
The purpose of this study is to assess the efficacy of ustekinumab, in adul...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09-03
Trial ID
NCT02437162
Treatments Being Tested
A medical research study in adult patients who have moderate to severe Croh...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00771667
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00307437
This study compare the genomics profiles in synovial biopsies obtained prio...
Status
Completed
Location
Dirk ELEWAUT
Start Date
2020-01-14
Trial ID
NCT04261010
Treatments Being Tested